Cellular Biomedicine Inc logo

CBMG - Cellular Biomedicine Inc News Story

$18.11 0.2  1.3%

Last Trade - 15/01/21

Sector
Healthcare
Size
Small Cap
Market Cap £259.6m
Enterprise Value £275.7m
Revenue £238k
Position in Universe 3633rd / 6547

BRIEF-Cellular Biomedicine Group Reports Q3 2020 Financial Results

Mon 9th November, 2020 10:42pm
Nov 9 (Reuters) - Cellular Biomedicine Group Inc  CBMG.O :
    * CELLULAR BIOMEDICINE GROUP REPORTS Q3 2020 FINANCIAL
RESULTS AND
BUSINESS HIGHLIGHTS
    * CELLULAR BIOMEDICINE GROUP INC - QTRLY LOSS PER SHARE
$0.88

Source text for Eikon:  ID:nPn8MVP4Xa 
Further company coverage:  CBMG.O 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.